STE: 10-K Risk Factor Changes

2025 vs 2024  ·  SEC EDGAR  ·  2026-05-22
Other years: 2024 vs 2023 · 2023 vs 2022
⚠ AI-Generated

The summary below was generated by an AI language model and may contain errors or omissions. All other content on this page is deterministically extracted from the original SEC EDGAR filing.

STE removed its COVID-19 pandemic risk factor while modifying 13 of its existing risk disclosures, indicating a shift from pandemic-specific concerns toward operational resilience and cost management priorities. The modified risks focus on business continuity hazards, Lean manufacturing effectiveness, and tax-related economic challenges, suggesting STE is emphasizing internal operational execution and broader macroeconomic uncertainties rather than pandemic-related disruptions. With 21 risks remaining unchanged, STE maintained its core risk framework while recalibrating emphasis toward structural business challenges.

✓ Deterministic extraction — no AI-generated data

Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.

0
New Risks
1
Removed
13
Modified
21
Unchanged
🔴 No Match in Current Filing

The COVID-19 pandemic disrupted our operations and could have a material adverse effect on our business and financial condition if further significant disruptions occur.

This section from the 2024 filing does not have a high-confidence textual match in the 2025 filing. It may have been removed, merged, or substantially reworded.

The COVID-19 pandemic, along with the response to the pandemic by governmental and other actors, disrupted our operations. We experienced temporary mandatory and voluntary facility closures in certain jurisdictions in which we operate and experienced less demand for certain of…

View 2024 text

The COVID-19 pandemic, along with the response to the pandemic by governmental and other actors, disrupted our operations. We experienced temporary mandatory and voluntary facility closures in certain jurisdictions in which we operate and experienced less demand for certain of our products and services as a result of reduced volume of medical procedures, and other factors, which we believe was exacerbated by the impact of stay-at-home orders and government responses to COVID-19. Additionally, the COVID-19 outbreak caused disruptions and rising costs in our labor supply and supply chain and distribution network. The impact of the COVID-19 pandemic and its residual effects continues to evolve and its ultimate duration, severity and disruption to our business, Customers and supply chain, and the related financial impact to us, cannot be accurately forecasted at this time. For instance, the enduring effects of the COVID-19 pandemic may put pressure on overall spending for our products and services, and may cause our Customers to modify spending priorities or delay or abandon purchasing decisions. Moreover, because a large number of our employees have worked and are expected to continue to work from home routinely, we may be subject to increased vulnerability to cyber and other information technology risks. We have modified, and may further modify, our business practices in response to the risks and negative impacts associated with the COVID-19 pandemic. However, there can be no assurance that these measures will be temporary or successful. Furthermore, future public health crises are possible and could involve some or all of the risks discussed above.

🟡 Modified Our operations, and those of our suppliers, are subject to a variety of business continuity hazards and risks, any of which could interrupt production or operations or otherwise adversely affect our performance, results, or value. 🔒
🟡 Modified If our continuing efforts to create a Lean business and in-source production to reduce costs are not successful, our profitability may be negatively impacted or our business otherwise might be adversely affected. 🔒
🟡 Modified Current economic and political conditions make tax rules in any jurisdiction subject to significant change. 🔒
🟡 Modified Supply chain disruption might increase our production costs, limit our production capabilities or curtail our operations. 🔒
🟡 Modified Our EO sterilization operations subject us to claims of liability and associated adverse effects. 🔒
🟡 Modified Expectations relating to corporate responsibility considerations expose us to potential liabilities, increased costs, reputational harm and other adverse effects on our business. 🔒
🟡 Modified Our business environment is highly competitive, and if we fail to compete successfully, our revenues and results of operations may be negatively impacted. 🔒
🟡 Modified A pandemic or similar public health crisis could have a material adverse impact on our ability to staff our operations. 🔒
🟡 Modified Our business and results of operations may be adversely affected if we are unable to recruit and retain qualified management and other personnel . 🔒
🟡 Modified We may fail to realize all of the anticipated benefits of our strategic business initiatives, as well as acquisitions, dispositions or joint ventures, or those benefits may take longer to realize than expected. 🔒
🟡 Modified We may be adversely affected by global climate change or by existing and future legal, regulatory or market responses to such change. 🔒
🟡 Modified The effects of geopolitical instability may adversely affect us and create significant risks and uncertainties for our business, with the ultimate impact dependent on future developments, which are highly uncertain and unpredictable. 🔒
🟡 Modified Our debt level or access to credit markets may limit our financial and business flexibility. 🔒
13 more changes in this filing

Full diff access, historical comparisons, and cross-company signal tracking.

Get full access — from $29/month Already a Pro subscriber? View full diff →